Heparin and Aspirin Versus Aspirin Alone for Prevention of Recurrent Pregnancy Loss
- Robert A. S. Roubey
- … show all 1 hide
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Laskin CA, Spitzer KA, Clark CA, et al.: Low molecular weight heparin and aspirin for recurrent pregnancy loss: results from the randomized, controlled HepASA trial. J Rheumatol 2009, 36:279–287.
• Of importance
The current standard of care for the prevention of recurrent pregnancy loss in women with antiphospholipid antibodies (aPL) is treatment with heparin (unfractionated or low molecular weight) and low-dose acetylsalicylic acid (ASA; aspirin) during pregnancy. Evidence supporting the benefit of this regimen over aspirin alone largely derives from two trials published in the late 1990s [1, 2]. In 2002, however, Farquharson et al.  found a high live birth rate with ASA alone and no benefit from the addition of heparin. The recent study by Laskin et al.  is an open-label, randomized controlled trial designed to address this important clinical issue.
This study intended to compare live birth rates in women with recurrent pregnancy loss associated with aPL, coa ...
- Rai R, Cohen H, Dave M, Regan L: Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies. BMJ 1997, 314:253–257.
- Kutteh WH: Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone. Am J Obstet Gynecol 1996, 174:1584–1589. CrossRef
- Farquharson RG, Quenby S, Greaves M: Antiphospholipid syndrome in pregnancy: a randomized, controlled trial of treatment. Obstet Gynecol 2002, 100:408–413. CrossRef
- Laskin CA, Spitzer KA, Clark CA, et al.: Low molecular weight heparin and aspirin for recurrent pregnancy loss: results from the randomized, controlled HepASA Trial. J Rheumatol 2009, 36:279–287. CrossRef
- Cowchock FS, Reece EA, Balaban D, et al.: Repeated fetal losses associated with antiphospholipid antibodies: a collaborative randomized trial comparing prednisone to low-dose heparin treatment. Am J Obstet Gynecol 1992, 166:1318–1323.
- Franklin RD, Kutteh WH: Antiphospholipid antibodies (APA) and recurrent pregnancy loss: treating a unique APA positive population. Hum Reprod 2002, 17:2981–2985. CrossRef
- Noble LS, Kutteh WH, Lashey N, et al.: Antiphospholipid antibodies associated with recurrent pregnancy loss: prospective, multicenter, controlled pilot study comparing treatment with low-molecular-weight heparin versus unfractionated heparin. Fertil Steril 2005, 83:684–690. CrossRef
- Pattison NS, Chamley LW, Birdsall M, et al.: Does aspirin have a role in improving pregnancy outcome for women with the antiphospholipid syndrome? A randomized controlled trial. Am J Obstet Gynecol 2000, 183:1008–1012. CrossRef
- Heparin and Aspirin Versus Aspirin Alone for Prevention of Recurrent Pregnancy Loss
Current Rheumatology Reports
Volume 12, Issue 1 , pp 1-3
- Cover Date
- Print ISSN
- Online ISSN
- Current Science Inc.
- Additional Links
- Author Affiliations
- 1. Department of Medicine and Thurston Arthritis Research Center, Division of Rheumatology, Allergy and Immunology, The University of North Carolina at Chapel Hill, CB #7280, Room 3330, Thurston Building, Chapel Hill, NC, 27599, USA